Log In
BCIQ
Print this Print this
 

CGEN-15052

  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionT cell activation inhibitor
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationLung cancer
Indication DetailsTreat lung cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today